229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-8.27%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-22.31%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-175.56%
Negative EBIT growth while VUZI is at 11.13%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-175.56%
Negative operating income growth while VUZI is at 10.47%. Joel Greenblatt would press for urgent turnaround measures.
-564.00%
Negative net income growth while VUZI stands at 11.25%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-561.11%
Negative EPS growth while VUZI is at 9.09%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-561.11%
Negative diluted EPS growth while VUZI is at 9.09%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.01%
Share reduction while VUZI is at 0.33%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.01%
Reduced diluted shares while VUZI is at 0.33%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-77.40%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-81.77%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
228.66%
Positive 10Y revenue/share CAGR while VUZI is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
12.03%
Positive 5Y CAGR while VUZI is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
-19.01%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
-70.50%
Negative 5Y OCF/share CAGR while VUZI is at 51.30%. Joel Greenblatt would question the firm’s operational model or cost structure.
-76.65%
Negative 3Y OCF/share CAGR while VUZI stands at 12.89%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
No Data
No Data available this quarter, please select a different quarter.
-168.49%
Negative 5Y net income/share CAGR while VUZI is 14.04%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-372.36%
Negative 3Y CAGR while VUZI is 36.24%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
-1.01%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-11.17%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y dividend/share CAGR while VUZI stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-100.00%
Negative near-term dividend growth while VUZI invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-0.27%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-26.28%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-1.72%
Negative asset growth while VUZI invests at 3.19%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-5.63%
We have a declining book value while VUZI shows 2.76%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-0.44%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
2.05%
We increase R&D while VUZI cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
3.62%
We expand SG&A while VUZI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.
